Aptose Biosciences' leukemia drug shows early promise
Aptose Biosciences (NASDAQ:APTO;TSX:APS), a clinical-stage oncology stock, achieved positive safety and response results from ...
Biomednewsbreaks - Kairos Pharma Ltd. (NYSE American: KAPA) Adds Huntsman Cancer Institute To Phase 2 Trial For Prostate Cancer Therapy
Kairos Pharma (NYSE American: KAPA) has added Huntsman Cancer Institute in Salt Lake City as a site for its Phase 2 clinical trial of ENV105 for cas ...